United Laboratories International Holdings (FRA:UNJ) Days Sales Outstanding : 64.68 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Days Sales Outstanding?

United Laboratories International Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was €311 Mil. United Laboratories International Holdings's Revenue for the six months ended in Dec. 2023 was €878 Mil. Hence, United Laboratories International Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 64.68.

The historical rank and industry rank for United Laboratories International Holdings's Days Sales Outstanding or its related term are showing as below:

FRA:UNJ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.12 Med: 61.06 Max: 120.86
Current: 61.83

During the past 13 years, United Laboratories International Holdings's highest Days Sales Outstanding was 120.86. The lowest was 51.12. And the median was 61.06.

FRA:UNJ's Days Sales Outstanding is ranked better than
60.36% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.38 vs FRA:UNJ: 61.83

United Laboratories International Holdings's Days Sales Outstanding increased from Dec. 2022 (59.51) to Dec. 2023 (64.68).

United Laboratories International Holdings Days Sales Outstanding Historical Data

The historical data trend for United Laboratories International Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Days Sales Outstanding Chart

United Laboratories International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

50.50

55.02

53.96

60.34

60.89

United Laboratories International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															53.92	59.94	59.51	61.82	64.68

Competitive Comparison of United Laboratories International Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Laboratories International Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Days Sales Outstanding falls into.

United Laboratories International Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

United Laboratories International Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (284.879	+	303.883)	/	2 )	/	1764.582	*	365
=	294.381					/	1764.582	*	365
=	60.89

United Laboratories International Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (318.164	+	303.883)	/	2 )	/	877.593	*	365 / 2
=	311.0235					/	877.593	*	365 / 2
=	64.68

United Laboratories International Holdings (FRA:UNJ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

United Laboratories International Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

United Laboratories International Holdings (FRA:UNJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ULIHF:USA 03933:Hong Kong UNJ:Germany

Address

No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG

Website

http://www.tul.com.cn

United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines